List of Studies ( Metabolite:Quinine)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004389 | AN007333 | Longitudinal Multi-omics Profiling Reveals Different Adaptation to Heat Stress in Genomically Divergent Lactating Sows | Feces | Pig | Environmental stress | North Carolina State University | LC-MS |
| ST004389 | AN007333 | Longitudinal Multi-omics Profiling Reveals Different Adaptation to Heat Stress in Genomically Divergent Lactating Sows | Milk | Pig | Environmental stress | North Carolina State University | LC-MS |
| ST004350 | AN007261 | The metabolic effects of succinylation and desuccinylation of HADHB at lysine 292 | Cultured cells | Rat | Nanchang University Second Affiliated Hospital | LC-MS | |
| ST004207 | AN006997 | Tumour sampling conditions perturb the metabolic landscape of clear cell renal cell carcinoma | Kidney | Human, Mouse | Cancer | University of Cambridge | LC-MS |
| ST004204 | AN006990 | The growth and virulence of S. aureus is inhibited by C. striatum by inhibiting its arginine biosynthesis pathway | Bacterial cells | Staphylococcus aureus | Chronic rhinosinusitis | Sun Yat-sen University | LC-MS |
| ST003439 | AN005670 | Metabolomics of human serum to support understanding of early metabolic shift in presymptomatic sepsis patients. (Part1 human metabolites) | Blood | Human | Sepsis | Leibniz Institute for Natural Product Research and Infection Biology Hans Knöll Institute | LC-MS |
| ST002820 | AN004594 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) | Blood | Human | Tufts Medical Center | Other | |
| ST002819 | AN004591 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) | Blood | Human | Tufts Medical Center | Other | |
| ST002787 | AN004534 | Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome | Feces | Human | Cancer | Wuhan University of Science and Technology | LC-MS |
| ST002536 | AN004171 | Effectors enabling adaptation to mitochondrial complex I loss in Hürthle cell carcinoma | Thyroid | Human | Cancer | Broad Institute of MIT and Harvard | LC-MS |
| ST002498 | AN004654 | Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort | Blood | Human | Cancer | Weill Cornell Medicine | LC-MS |
| ST002405 | AN003919 | Stool global metabolite levels in peanut allergy (Part 2) | Feces | Human | Peanut allergy | Icahn School of Medicine at Mount Sinai | LC-MS |
| ST002155 | AN003530 | Longitudinal metabolomic stool dynamics in primary C. difficile infections | Feces | Human | Bacterial infection | Brigham and Women's Hospital | LC-MS |
| ST002089 | AN003410 | Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. | Blood | Human | COPD | National Jewish Health | LC-MS |
| ST002088 | AN003406 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema | Blood | Human | COPD | National Jewish Health | LC-MS |
| ST002017 | AN003287 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) | Blood | Human | Vanderbilt University Medical Center | LC-MS | |
| ST001940 | AN003155 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | LC-MS |
| ST001940 | AN003156 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | LC-MS |
| ST001940 | AN003157 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | LC-MS |
| ST001940 | AN003158 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | LC-MS |
| ST001863 | AN003020 | Analysis of Bxa induced metabolic changes in epithelial cells | Cultured cells | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST001749 | AN002849 | REACH Metabolomics Study | Blood | Human | Alzheimers disease | University of Wisconsin-Madison | LC-MS |
| ST001708 | AN002782 | Oxylipin biosynthesis reinforces cellular senescence through a RAS/p53 feedback loop and allows detection of senolysis | Blood | Mouse | Buck Institute for Research on Aging | LC-MS | |
| ST001639 | AN002681 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort | Blood | Human | COPD | National Jewish Health | LC-MS |
| ST001521 | AN002533 | Plasma metabolites of known identity profiled using hybrid nontargeted methods (part-III) | Blood | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST001519 | AN002525 | Stool metabolites of known identity profiled using hybrid nontargeted methods (part-I) | Feces | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST001412 | AN002362 | Metabolomics study in Plasma of Obese Patients with Neuropathy Identifies Potential Metabolomics Signatures | Blood | Human | Obesity | University of Michigan | LC-MS |
| ST001411 | AN002361 | Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark | Blood | Human | Obesity | University of Michigan | LC-MS |
| ST001237 | AN002055 | Metabolic responses to PD1 immune-checkpoint blockade and association with therapeutic benefits - Part III | Blood | Human | Cancer | Broad Institute of MIT and Harvard | LC-MS |
| ST001236 | AN002054 | Metabolic responses to PD1 immune-checkpoint blockade and association with therapeutic benefits - Part II | Blood | Human | Cancer | Broad Institute of MIT and Harvard | LC-MS |
| ST000976 | AN001597 | GC6-74 matabolomic of TB (Part 3: Plasma_RPMI) | Blood | Human | Tuberculosis | Max Planck Institute for Infection Biology | LC-MS |
| ST000923 | AN001513 | Longitudinal Metabolomics of the Human Microbiome in Inflammatory Bowel Disease | Feces | Human | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST000444 | AN000695 | Preconcentration of organic solutes in urine by bubble bursting | Urine | Human | V.I. Kulakov Research Center for Obstetrics, Gynecology and Perinatology | LC-MS |
